期刊文献+

临床常见产ampC β-内酰胺酶菌株中染色质ampD基因突变位点的研究 被引量:2

Exploration of the mutations of genomic ampD from the clinical isolates producing ampC β-lactamases
下载PDF
导出
摘要 目的了解临床常见产ampCβ-内酰胺酶菌株中染色体ampD的分布及其突变位点。方法41株临床常见产ampCβ-内酰胺酶菌株(阴沟肠杆菌,肺炎克雷伯菌,鲍曼不动杆菌,铜绿假单胞菌)分离自医院感染样本,抽提其染色质DNA,PCR法扩增ampD基因并连接入pMD19-T载体后,再行PCR确定其存在。双链测序后比对染色体ampD基因的突变位点。结果41株细菌的基因组中,使用PCR法扩增出染色体ampD基因有36株,并成功测定了其ampD基因的序列;比对后发现阴沟肠杆菌、肺炎克雷伯菌、鲍曼不动杆菌和铜绿假单胞菌的染色体ampD基因的核苷酸序列差异较大。染色质ampD易突变位点分析统计表明,这些细菌的ampD基因的平均突变率分别为:64.5%、100.0%、97.0%和95.0%。结论大部分临床常见产ampCβ-内酰胺酶菌株含有ampD基因,并且有较高的突变率。 Objective To explore the mutations of the genomic ampD from the clinical isolates producing ampC β-lactamases. Methods Forty-one bacilli produced ampC β-lactamases were isolated from the nosocomial infection. The genomic DNA was extracted, genomic ampD was amplified using PCR, ligated into pMD19-T vector, and sequenced. Mutation sites were analyzed. Results Of the 41 clinical isolates, 36 were identified to contain the genomic ampD sequences, and their sequences were successfully measured. The results of the mutation analysis showed that the average mutation rates of Enterobacter cloacae, Klebsiella pneumonia, Acinetobacter baumannii and Pseudomonsa aeruginosa were 64. 45 %, 100.00 %, 97.00%, and 95.00%, respectively. Conclusions A large proportion of the clinical isolates producing ampC lactamases contained genomic ampD which is highly mutated.
出处 《复旦学报(医学版)》 CAS CSCD 北大核心 2009年第3期337-341,357,共6页 Fudan University Journal of Medical Sciences
基金 上海市科委重点科研基金项目(054119509)
关键词 AMPC Β-内酰胺酶 ampD 突变 PCR ampC β-lactamases genomic ampD mutations PCR
  • 相关文献

参考文献12

二级参考文献47

  • 1徐英春,陈民钧.AmpC酶与革兰阴性菌的耐药特征[J].中华微生物学和免疫学杂志,2001,21(S1):18-20. 被引量:24
  • 2李家泰.临床药理学[M].北京:人民卫生出版社,1997.901-902.
  • 3李家泰.临床病理学[M].北京:人民卫生出版社,1997.575.
  • 4Korfmann G Wiedemann B.Genetic control of β-lactamase production in Enterobacter cloacae[J].Rev Infet Dis,1988,10:793-793.
  • 5[1]Rice LB,Bonomo RA.Genetic and biochemical mechanisms of bacterial resistance to antimicrobial agents.In:Lorian V,ed.Antibiotics in laboratory medicine.5th ed.Philadelphia:Williams & Wilkins,2005.441-509.
  • 6[3]National Committee for Clinical Laboratory Standards.Performance standards for antimicrobial susceptibility testing;12th informational supplement(M100-S12).Wayne:NCCLS,2002.
  • 7[4]Coudron PE,Moland ES,Thomson KS.Occurrence and detection of AmpC β-lactamases among Escherichia coli,Klebsiella pneumoniae,and Proteus mirabilis isolates at a veterans medical center.J Clin Microbiol,2000,38:1791-1796.
  • 8[5]Hidri N,Barnaud G,Decre D,et al.Resistance to ceftazidime is associated with a S220Y substitution in the omega loop of the ampC beta-lactamase of a Serratia marcescens clinical isolate.J Antimicrob Chemother,2005,55:496-499.
  • 9[6]Mammeri H,Nazic H,Naas T,et al.ampC beta-lactamase in an Escherichia coli clinical isolate confers resistance to expanded-spectrum cephalosporins.Antimicrob Agents Chemother,2004,48:4050-4053.
  • 10[7]Mammeri H,Poirel L,Bemer P,et al.Resistance to cefepime and cefpirome due to a 4-amino-acid deletion in the chromosome-encoded ampC beta-lactamase of a Serratia marcescens clinical isolate.Antimicrob Agents Chemother,2004,48:716-720.

共引文献127

同被引文献17

  • 1刘晶,多丽波.染色体介导的AmpC酶研究进展[J].国际检验医学杂志,2006,27(7):641-643. 被引量:13
  • 2沈定树,周雪艳,袁远,徐玖飞,陈慧红,夏东,齐娟飞,陈东.肠杆菌诱导型AmpC酶对第三代和第四代头孢菌素的影响[J].中国微生态学杂志,2006,18(5):384-385. 被引量:9
  • 3段金菊,刘卓拉,张润梅,张瑞琴,杜娟,刘国栋,徐辉,康建邦.三维实验对产AmpC酶革兰阴性菌的检测及分析[J].中国药物与临床,2007,7(4):257-260. 被引量:10
  • 4Chou AF, Yano EM, McCoy KD, et al. Structural and process factors affecting the implementation of antimicrobial resistance prevention and control strategies in U. S. hospitals[J]. Health Care Management Rev ,2008,33(4) :308 - 322.
  • 5Tan TT. " Future" threat of gram-negative resistance in Singapore[J]. Ann Acad Med Sigapore, 2008, 37 (10) : 884 - 890.
  • 6Kaneko K, Okamoto R, Nakano R, et al. Gene mutations responsible for overexpression of AmpC β-lactamase is some clinical isolates of Enterobacter cloacae[J].J Clinical Microbiol,2005,43(6) :2 955 - 2 958.
  • 7Choi SH, Lee JE, Park SJ, et al. Emergence of antibiotic resistance during therapy for infections caused by Enterobacteriaceae producing AmpC β-lactamase: Implications for antibiotic use[J]. Antimicrob Agents Chemother, 2008,52 (3) : 995 - 1 000.
  • 8Garner JS,Jarvis WR, Emori TG, et al. CDC definitions for nosocomial infections[J]. Am J Infect Control, 1988,16 (3) .- 126 - 140.
  • 9Bauernfeind A, Chong Y, Lee K. Plasmid-encoded AmpC beta-lactamases: How far have we gone 10 years after the discovery? [J]. Yonsei Med J , 1998,39(6) :520- 525.
  • 10Tracz DM, Boyd DA, Hizon R,et al. ampC gene expression in promoter mutants of cefoxitin-resistant Escherichia coli clinical isolates [ J ]. FEMS Microbiol Lett, 2007, 270 ( 2 ) : 265 - 271.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部